Akorn signs deal for eye solution
BUFFALO GROVE -- Akorn Inc. said Thursday it signed a five-year manufacturing and supply agreement with a major U.S. pharmaceutical company. Akorn will be responsible for the manufacturing and supply of the ophthalmic drug product, which will be made in Somerset, N.J. Akorn expects to launch this product by mid-year. Terms of the deal were not disclosed.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.